A HERITAGE OF INNOVATION AND LEADERSHIP
Lantheus Medical Imaging, a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease.
Our proven success in discovering, developing and commercializing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. Lantheus has a rich heritage and expertise in cardiovascular imaging and nuclear medicine, having pioneered many of the most significant products used in medical imaging.
Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We also have a full clinical and preclinical development pipeline of next-generation and first-in-class products using Positron Emission Tomography (PET) and MRI technologies.
Our vision is to be the leading provider of innovative medical imaging solutions to improve human life. We are committed to developing next generation and first-in-class imaging agents to assist physicians in the diagnosis of heart, vascular and other diseases.
With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.
|
|
Investor Relations
Quarterly SEC Filings
Recent News
05/17/12
Lantheus Appoints New Member to its Board of Directors
05/09/12
Lantheus Medical Imaging Announces Manufacturing and Supply Agreements with Jubilant HollisterStier LLC for Cardiolite® and Neurolite®
05/03/12
Lantheus Medical Imaging Announces Appointment of
Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality
|
|
Company Spotlight
Lantheus Appoints New Member to its Board of Directors
Addition of Samuel R. Leno
Further Enhances Board’s
Financial Expertise
No. BILLERICA, Mass. (May 17, 2012) – Lantheus MI Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the appointment of Samuel R. Leno as a member of its Board of Directors.
click here for the press release |
